Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action

Here, we review the data on mechanisms inhibiting cytotoxic effect of anthrax toxin on the immune system cells. Various disease forms, immunopathogenesis and contemporary methods for anthrax treatment are discussed. In addition, an anthrax toxin was outlined, whereas structural and functional organi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: V. V. Firstova, I. G. Shemyakin, I. A. Dyatlov
Formato: article
Lenguaje:RU
Publicado: Sankt-Peterburg : NIIÈM imeni Pastera 2020
Materias:
Acceso en línea:https://doaj.org/article/4a376f50f66641bb8895bee6f747be03
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4a376f50f66641bb8895bee6f747be03
record_format dspace
spelling oai:doaj.org-article:4a376f50f66641bb8895bee6f747be032021-11-22T07:09:53ZCurrent understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action2220-76192313-739810.15789/2220-7619-2019-5-6-639-647https://doaj.org/article/4a376f50f66641bb8895bee6f747be032020-02-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/721https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Here, we review the data on mechanisms inhibiting cytotoxic effect of anthrax toxin on the immune system cells. Various disease forms, immunopathogenesis and contemporary methods for anthrax treatment are discussed. In addition, an anthrax toxin was outlined, whereas structural and functional organization of the protective antigen, lethal and edema factors was detailed. A mechanism for association of a protective antigen and lethal factor, protective antigen and edema factor leading to formation of a lethal toxin and edema toxin, respectively, was described. Participation of protective antigen domains in the process of interaction with surface receptors of imunocompetent cells as well as features of binding a protective antigen with lethal factor and edema factor are discussed. A mechanism of endosomal toxin complex internalization and subsequent transfer of effector molecules to the cytosol are described. Effects of the lethal factor and the edema factor on components of eukaryotic cells as well as cytotoxicity mechanisms are analyzed. The approaches to block anthrax toxin action at various stages of toxicoemia have been analyzed based on previously uncovered sequential signs of cytotoxic activity for Bacillus anthracis toxins. Currently available chimeric and humanized monoclonal antibodies are capable of neutralizing B. anthracis toxins at diverse assembly stages, particularly considering the drugs inhibiting: inter-receptor interaction between protective antigen with eukaryotic cells; furin-like enzymes activating prepore assembly; protective antigen oligomerization; binding of the lethal factor or edema factor to the protective antigen; translocation of the lethal factor or the edema factor into cell cytosol; transport of protective antigen with lethal factor or edema factor from endosomes; enzymatic activity of lethal factor or edematous factor. The anti-toxin agents approved for anthrax prevention and treatment in Russia and worldwide are discussed. The limitations of anti-toxin agents and perspectives for their improvement are also described including inhibition of lethal factor activity, interference with integration of toxin components, blockade of interactions between toxic complexes and immune cell receptors.V. V. FirstovaI. G. ShemyakinI. A. DyatlovSankt-Peterburg : NIIÈM imeni Pasteraarticleb. anthracisprotective antigenlethal factoredema factortoxinimmunopathogenesisInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 9, Iss 5-6, Pp 639-647 (2020)
institution DOAJ
collection DOAJ
language RU
topic b. anthracis
protective antigen
lethal factor
edema factor
toxin
immunopathogenesis
Infectious and parasitic diseases
RC109-216
spellingShingle b. anthracis
protective antigen
lethal factor
edema factor
toxin
immunopathogenesis
Infectious and parasitic diseases
RC109-216
V. V. Firstova
I. G. Shemyakin
I. A. Dyatlov
Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action
description Here, we review the data on mechanisms inhibiting cytotoxic effect of anthrax toxin on the immune system cells. Various disease forms, immunopathogenesis and contemporary methods for anthrax treatment are discussed. In addition, an anthrax toxin was outlined, whereas structural and functional organization of the protective antigen, lethal and edema factors was detailed. A mechanism for association of a protective antigen and lethal factor, protective antigen and edema factor leading to formation of a lethal toxin and edema toxin, respectively, was described. Participation of protective antigen domains in the process of interaction with surface receptors of imunocompetent cells as well as features of binding a protective antigen with lethal factor and edema factor are discussed. A mechanism of endosomal toxin complex internalization and subsequent transfer of effector molecules to the cytosol are described. Effects of the lethal factor and the edema factor on components of eukaryotic cells as well as cytotoxicity mechanisms are analyzed. The approaches to block anthrax toxin action at various stages of toxicoemia have been analyzed based on previously uncovered sequential signs of cytotoxic activity for Bacillus anthracis toxins. Currently available chimeric and humanized monoclonal antibodies are capable of neutralizing B. anthracis toxins at diverse assembly stages, particularly considering the drugs inhibiting: inter-receptor interaction between protective antigen with eukaryotic cells; furin-like enzymes activating prepore assembly; protective antigen oligomerization; binding of the lethal factor or edema factor to the protective antigen; translocation of the lethal factor or the edema factor into cell cytosol; transport of protective antigen with lethal factor or edema factor from endosomes; enzymatic activity of lethal factor or edematous factor. The anti-toxin agents approved for anthrax prevention and treatment in Russia and worldwide are discussed. The limitations of anti-toxin agents and perspectives for their improvement are also described including inhibition of lethal factor activity, interference with integration of toxin components, blockade of interactions between toxic complexes and immune cell receptors.
format article
author V. V. Firstova
I. G. Shemyakin
I. A. Dyatlov
author_facet V. V. Firstova
I. G. Shemyakin
I. A. Dyatlov
author_sort V. V. Firstova
title Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action
title_short Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action
title_full Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action
title_fullStr Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action
title_full_unstemmed Current understanding of Bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action
title_sort current understanding of bacillus anthracis toxin molecules organization and approaches for blocking their cytotoxic action
publisher Sankt-Peterburg : NIIÈM imeni Pastera
publishDate 2020
url https://doaj.org/article/4a376f50f66641bb8895bee6f747be03
work_keys_str_mv AT vvfirstova currentunderstandingofbacillusanthracistoxinmoleculesorganizationandapproachesforblockingtheircytotoxicaction
AT igshemyakin currentunderstandingofbacillusanthracistoxinmoleculesorganizationandapproachesforblockingtheircytotoxicaction
AT iadyatlov currentunderstandingofbacillusanthracistoxinmoleculesorganizationandapproachesforblockingtheircytotoxicaction
_version_ 1718417915373420544